According to Moderna, low-dose COVID vaccines are effective for children under 6 years of age

Moderna has interim results from its tests, Omicron wave There are no new safety concerns.

According to the company, vaccine efficacy was 37.5% for children aged 2 to 6 years and 43.7% for children aged 6 months to 2 years. Blood samples from clinical trial participants showed that the vaccine showed “strong neutralizing antibody responses in both age groups.”

“Given the need for a vaccine against COVID-19 in infants, we are working with the US FDA and regulatory agencies around the world to submit these data as soon as possible,” said Moderna CEO. Stéphane Bancel said: release We will announce new results.

Elena Rosales is applauded while checking her new band-aid after receiving her shot during the Modelna COVID-19 vaccine trial on December 7, 2021.

(Brian Cassella / Chicago Tribune / Tribune News Service via Getty Images

Moderna will also submit data to the FDA to vaccinate older children, Bansel said. Moderna vaccines are currently available for people over the age of 18.

As with adults, the company’s original request to inoculate two doses of 100 micrograms has been stalled for months. FDA concerns Around the side effects of rare heart inflammation. Vaccines tested for younger children weigh only 25 micrograms per dose. Moderna also says she plans to study booster doses for children.

Moderna announced with Pfizer BioNTech He said he would delay the submission of data from the COVID-19 vaccine trial. For the youngest age group, Citing disappointing data for Omicron from two child-sized doses of their vaccine. Data from testing three doses of the vaccine are expected “early April”.

Biden administration was planning During February Following FDA approval and recommendations from the Centers for Disease Control and Prevention, we will deploy approximately 10 million doses. It also needs to be approved for eligibility.

“Unfortunately, it turns out that the regimen is not enough to give what appears to be an appropriate or optimal immune response with protection. Therefore, this is almost certainly a child in a cohort of that age. It seems to be a three-dose vaccine for the drug, which is why it takes so long. ” Dr. Anthony Fauci, Chief Medical Advisor to the President, Said on Tuesday During an event hosted by The Washington Post.

FDA had Initial plan An external advisor will be convened on February 15 to weigh the benefits and risks of BioNTech and Pfizer’s requirements.The same committee — Vaccine and Related Biological Products Advisory Board — is already Will meet In 2 weeks to discuss the COVID-19 vaccine Booster shot..

Millions of children under the age of five were infected with COVID-19 and more than 400 died, according to the report. To CDC data..

“Sure, the FDA, as always, wants to get it right, so when they approve something, they can be confident that it’s effective and safe,” Fauci said. Told.

According to Moderna, low-dose COVID vaccines are effective for children under 6 years of age

Source link According to Moderna, low-dose COVID vaccines are effective for children under 6 years of age

Related Articles

Back to top button